Literature DB >> 24332650

miR-92a/DUSP10/JNK signalling axis promotes human pancreatic cancer cells proliferation.

Gengsheng He1, Lei Zhang2, Qing Li3, Longqiu Yang4.   

Abstract

Pancreatic cancer is one of the most common types of cancers in the whole world with a poor prognosis. Finding out how the cancer form and develop is the most important way to cure this cancer. miRNAs, 21-22 nucleotides regulatory small non-coding RNAs, have been found to be critical involved in the growth of pancreatic cancer. In this study, we found that miR-92a was up regulated in three kinds of human pancreatic cancer cell lines. There is a correlation between miR-92a and malignant degree of human pancreatic cancer cell lines. Then we found that miR-92a was essential for promoting cell proliferation in human pancreatic cancer. Inhibition of the function of miR-92a repressed the proliferation of pancreatic cancer cells. Further, we found that miR-92a enhanced the activation of JNK signalling pathway by directly targeting the JNK signalling inhibitor DUSP10. DUSP10 is responsible for miR-92a induced JNK signalling and cell proliferation. Altogether, our study showed a miR-92a/DUSP10/JNK signalling pathway that plays an important role in regulating the proliferation of pancreatic cancer cells.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  DUSP10; MiR-92a; Pancreatic cancer; Proliferation

Mesh:

Substances:

Year:  2013        PMID: 24332650     DOI: 10.1016/j.biopha.2013.11.004

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  20 in total

1.  MicroRNA-92 promotes invasion and chemoresistance by targeting GSK3β and activating Wnt signaling in bladder cancer cells.

Authors:  Haifeng Wang; Changxing Ke; Xingyong Ma; Qinghua Zhao; Mingying Yang; Wei Zhang; Jiansong Wang
Journal:  Tumour Biol       Date:  2016-11-09

Review 2.  Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application.

Authors:  V Taucher; H Mangge; J Haybaeck
Journal:  Cell Oncol (Dordr)       Date:  2016-04-08       Impact factor: 6.730

3.  MicroRNA-92a promotes cell viability and invasion in cervical cancer via directly targeting Dickkopf-related protein 3.

Authors:  Shengtian Luo; Na Li; Shaohua Yu; Lichun Chen; Chunying Liu; Jiawei Rong
Journal:  Exp Ther Med       Date:  2017-06-13       Impact factor: 2.447

4.  Expression and prognostic value of miR-92a in patients with gastric cancer.

Authors:  Chuanli Ren; Wenshu Wang; Chongxu Han; Hui Chen; Deyuan Fu; Yulin Luo; Hanyu Yao; Daxin Wang; Li Ma; Lin Zhou; Dongsheng Han; Ming Shen
Journal:  Tumour Biol       Date:  2016-01-20

Review 5.  MicroRNA in pancreatic cancer.

Authors:  Keiichi Yonemori; Hiroshi Kurahara; Kosei Maemura; Shoji Natsugoe
Journal:  J Hum Genet       Date:  2016-06-02       Impact factor: 3.172

6.  MicroRNA-92a promotes growth, metastasis, and chemoresistance in non-small cell lung cancer cells by targeting PTEN.

Authors:  Ping Ren; Fangchao Gong; Yan Zhang; Jindong Jiang; Hong Zhang
Journal:  Tumour Biol       Date:  2015-10-02

Review 7.  Regulatory Roles of MAPK Phosphatases in Cancer.

Authors:  Heng Boon Low; Yongliang Zhang
Journal:  Immune Netw       Date:  2016-04-28       Impact factor: 6.303

8.  Differential Sensitivity of Target Genes to Translational Repression by miR-17~92.

Authors:  Hyun Yong Jin; Hiroyo Oda; Pengda Chen; Chao Yang; Xiaojuan Zhou; Seung Goo Kang; Elizabeth Valentine; Jennifer M Kefauver; Lujian Liao; Yaoyang Zhang; Alicia Gonzalez-Martin; Jovan Shepherd; Gareth J Morgan; Tony S Mondala; Steven R Head; Pyeung-Hyeun Kim; Nengming Xiao; Guo Fu; Wen-Hsien Liu; Jiahuai Han; James R Williamson; Changchun Xiao
Journal:  PLoS Genet       Date:  2017-02-27       Impact factor: 5.917

9.  MicroRNAs of the mir-17~92 cluster regulate multiple aspects of pancreatic tumor development and progression.

Authors:  Brian Quattrochi; Anushree Gulvady; David R Driscoll; Makoto Sano; David S Klimstra; Christopher E Turner; Brian C Lewis
Journal:  Oncotarget       Date:  2017-05-30

Review 10.  Molecular Imaging with MRI: Potential Application in Pancreatic Cancer.

Authors:  Chen Chen; Chang Qiang Wu; Tian Wu Chen; Meng Yue Tang; Xiao Ming Zhang
Journal:  Biomed Res Int       Date:  2015-10-22       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.